68 IMMUNOREACT 13: IMMUNE SURVEILLANCE MARKERS IN THE CLINICAL MANAGEMENT OF STAGE II RECTAL CANCERGiorgio Rivella, Marco Scarpa, Ignazio Castagliuolo et al.|Gastroenterology|2024Cited by 0
IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesionsBeatrice Salmaso, Alessandra Piccioli, Melania Scarpa et al.|Scientific Reports|2024Cited by 0